To date, oncologists have not seen much success with immunotherapy for neuroendocrine tumors.
Xianxin Hua, MD, PhD
Advertisement
Articles by Xianxin Hua, MD, PhD
Advertisement
Latest Updated Articles
Investigators Explore Immunotherapy for NETs as Incidence GrowsPublished: May 31st 2022 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
5